A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
21 Jun 2022
Only 50.5% of Medicare beneficiaries ages 19 or older had received an influenza vaccine during the 2018 to 2019 flu season, and vaccination rates were significantly higher among White beneficiaries than Black or Hispanic beneficiaries.
16 Nov 2021
The CDC is anticipating a resumption of seasonal flu activity in the U.S., but the potential effects of the COVID-19 pandemic this year remain unknown.
1 Oct 2021
Results of vaccine trials were positive, but concerns arose about safety.
15 Sep 2020
An accompanying editorial noted that a comprehensive and proactive approach to vaccine safety is needed now more than ever amid research into COVID-19 vaccines.
1 Sep 2020
Infectious diseases experts offered guidance on the use of antibody tests in practice, a remdesivir trial showed disappointing results, the CDC recommended flu vaccination for people six months and up, and a study reported post-ICU outcomes of patients with COVID-19.
25 Aug 2020
Clinicians could benefit from an injection technique “tune-up” in needle placement and needle length, an editorial suggested.
23 Jun 2020
Vaccination programs focusing on elderly patients may require supplemental strategies focused on vaccinating children and other high-risk populations to effectively reduce morbidity and mortality, the authors wrote.
3 Mar 2020
Updated recommendations from the Advisory Committee on Immunization Practices (ACIP) affect vaccinations for influenza and human papillomavirus, among others.
4 Feb 2020
ACP convened an Advisory Group to discuss barriers to adult immunization, with the goal of identifying potential ways for ACP to address them on a population health level.
1 Oct 2019